Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 4
2008 4
2009 7
2010 6
2011 6
2012 2
2014 4
2015 2
2016 6
2017 5
2018 3
2019 4
2020 7
2021 3
2022 3
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
IL-6 in inflammation, immunity, and disease.
Tanaka T, Narazaki M, Kishimoto T. Tanaka T, et al. Among authors: narazaki m. Cold Spring Harb Perspect Biol. 2014 Sep 4;6(10):a016295. doi: 10.1101/cshperspect.a016295. Cold Spring Harb Perspect Biol. 2014. PMID: 25190079 Free PMC article. Review.
Historical overview of the interleukin-6 family cytokine.
Kang S, Narazaki M, Metwally H, Kishimoto T. Kang S, et al. Among authors: narazaki m. J Exp Med. 2020 May 4;217(5):e20190347. doi: 10.1084/jem.20190347. J Exp Med. 2020. PMID: 32267936 Free PMC article. Review.
Interleukin (IL-6) Immunotherapy.
Tanaka T, Narazaki M, Kishimoto T. Tanaka T, et al. Among authors: narazaki m. Cold Spring Harb Perspect Biol. 2018 Aug 1;10(8):a028456. doi: 10.1101/cshperspect.a028456. Cold Spring Harb Perspect Biol. 2018. PMID: 28778870 Free PMC article. Review.
Targeting Interleukin-6 Signaling in Clinic.
Kang S, Tanaka T, Narazaki M, Kishimoto T. Kang S, et al. Among authors: narazaki m. Immunity. 2019 Apr 16;50(4):1007-1023. doi: 10.1016/j.immuni.2019.03.026. Immunity. 2019. PMID: 30995492 Free article. Review.
Regulation of IL-6 in Immunity and Diseases.
Tanaka T, Narazaki M, Masuda K, Kishimoto T. Tanaka T, et al. Among authors: narazaki m. Adv Exp Med Biol. 2016;941:79-88. doi: 10.1007/978-94-024-0921-5_4. Adv Exp Med Biol. 2016. PMID: 27734409 Review.
VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway.
Lee C, Chen R, Sun G, Liu X, Lin X, He C, Xing L, Liu L, Jensen LD, Kumar A, Langer HF, Ren X, Zhang J, Huang L, Yin X, Kim J, Zhu J, Huang G, Li J, Lu W, Chen W, Liu J, Hu J, Sun Q, Lu W, Fang L, Wang S, Kuang H, Zhang Y, Tian G, Mi J, Kang BA, Narazaki M, Prodeus A, Schoonjans L, Ornitz DM, Gariepy J, Eelen G, Dewerchin M, Yang Y, Ou JS, Mora A, Yao J, Zhao C, Liu Y, Carmeliet P, Cao Y, Li X. Lee C, et al. Among authors: narazaki m. Signal Transduct Target Ther. 2023 Aug 18;8(1):305. doi: 10.1038/s41392-023-01539-9. Signal Transduct Target Ther. 2023. PMID: 37591843 Free PMC article.
Current status and prospects of IL-6-targeting therapy.
Narazaki M, Kishimoto T. Narazaki M, et al. Expert Rev Clin Pharmacol. 2022 May;15(5):575-592. doi: 10.1080/17512433.2022.2097905. Epub 2022 Jul 7. Expert Rev Clin Pharmacol. 2022. PMID: 35791866 Review.
Secretion of mitochondrial DNA via exosomes promotes inflammation in Behçet's syndrome.
Konaka H, Kato Y, Hirano T, Tsujimoto K, Park J, Koba T, Aoki W, Matsuzaki Y, Taki M, Koyama S, Itotagawa E, Jo T, Hirayama T, Kawai T, Ishii KJ, Ueda M, Yamaguchi S, Akira S, Morita T, Maeda Y, Nishide M, Nishida S, Shima Y, Narazaki M, Takamatsu H, Kumanogoh A. Konaka H, et al. Among authors: narazaki m. EMBO J. 2023 Oct 16;42(20):e112573. doi: 10.15252/embj.2022112573. Epub 2023 Sep 4. EMBO J. 2023. PMID: 37661814 Free PMC article.
Therapeutic targeting of the interleukin-6 receptor.
Tanaka T, Narazaki M, Kishimoto T. Tanaka T, et al. Among authors: narazaki m. Annu Rev Pharmacol Toxicol. 2012;52:199-219. doi: 10.1146/annurev-pharmtox-010611-134715. Epub 2011 Sep 9. Annu Rev Pharmacol Toxicol. 2012. PMID: 21910626 Review.
68 results